A case of cerebral hypomyelination with spondylo-epi-metaphyseal dysplasia
Shihoko Kimura-Ohba1, Kuriko Kagitani-Shimono, Natsuko Hashimoto
1Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan. skimura@ped.med.osaka-u.ac.jp
Insights
This study presents a rare case of hypomyelination with skeletal abnormalities in a male patient. Genetic testing ruled out common causes, suggesting a novel gene mutation affecting both brain myelination and skeletal development.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Pelizaeus-Merzbacher disease (PMD) and Pelizaeus-Merzbacher-like disease (PMLD) are rare X-linked disorders characterized by hypomyelination.
- Genetic mutations in the proteolipid protein (PLP)-1 gene are the primary cause of classical PMD.
Observation:
- A male patient presented with developmental delay, nystagmus, and ataxia at 1 year of age.
- At 4 years, he was diagnosed with hypomyelination and skeletal abnormalities, including severe growth retardation and skeletal dysplasia.
- Brain MRI showed diffuse hypomyelination, and skeletal X-rays revealed dysplasia consistent with spondylo-epi-metaphyseal dysplasia.
Findings:
- Genetic analysis excluded mutations or duplications in the PLP-1 gene and mutations in the discoidin domain receptor (DDR) 2 gene.
- Array comparative genomic hybridization (CGH) did not identify any causal copy number variations.
- The patient's condition represents a rare co-morbidity of hypomyelination and skeletal abnormalities without identified genetic causes.
Implications:
- The findings suggest a potential novel genetic etiology for the co-occurrence of hypomyelination and skeletal dysplasia.
- Further research is needed to identify the specific gene mutation responsible for this complex phenotype.
- This case highlights the diagnostic challenges in rare neurological and skeletal disorders and the importance of comprehensive genetic investigation.
Abstract:
We reported on a male patient with rare leukoencephalopathy and skeletal abnormalities. The condition was first noticed as a developmental delay, nystagmus and ataxia at 1 year of age. At 4 years of age, he was diagnosed as hypomyelination with skeletal abnormalities from clinical features, brain magnetic resonance imaging (MRI) and skeletal X-rays. His brain MRI revealed diffuse hypomyelination. These findings suggested the classical type of Pelizaeus-Merzbacher disease (PMD) caused by proteolipid protein (PLP)-1 gene or Pelizaeus-Merzbacher-like disease (PMLD). However, we found neither mutation nor duplication of PLP-1. The patient had severe growth retardation and general skeletal dysplasia compatible with spondylo-epi-metaphyseal dysplasia; however the mutation of discoidin domain receptor (DDR) 2 gene was absent. The co-morbidity of hypomyelination with skeletal abnormalities is rare. We performed array CGH and no causal copy number variation was recognized. Alternatively, this condition may have been caused by a mutation of the gene encoding a molecule that functions in both cerebral myelination and skeletal development.
Related Concept Videos
Multiple Sclerosis l: Introduction
Inborn Errors of Metabolism
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Encephalitis l: Introduction
Neurulation
Cerebral Edema ll: Pathophysiology

